2013年9月25日,FDA頒布了移動醫(yī)療應(yīng)用的正式導(dǎo)則,針對日益廣泛應(yīng)用在醫(yī)療器械和移動互聯(lián)網(wǎng)和終端設(shè)備上的軟體(Mobile Apps),硬件等提出了建設(shè)性意見和指南。并將監(jiān)管重點放在用于維持人體生命等高風(fēng)險的器械上;FDA將不斷改進和增加新的監(jiān)管要求。
FDA will focus its oversight on medical mobile apps that meet the definition of device in the Federal Food, Drug, and Cosmetic Act and are intended to:
- transform a mobile device into a medical device regulated by FDA; or
- be used as an accessory to a medical device regulated by the FDA.
FDA intends to exercise enforcement discretion for other mobile apps. This focuses FDA's regulatory priorities on the small subset of mobile medical apps that could present a greater risk to health.
詳細(xì)信息請訪問FDA在線:
FDA 移動醫(yī)療應(yīng)用正式導(dǎo)則頒布:
Mobile Medical Applications
FDA移動醫(yī)療應(yīng)用相關(guān)法規(guī)和指南:
GHTF格慧泰福國際認(rèn)證服務(wù)部編譯整理
-
服務(wù)流程資料添加中....
- 官方收費資料添加中....
- 基礎(chǔ)法規(guī)資料添加中....
- 相關(guān)服務(wù)資料添加中....